| NEWS
by: Motley Rice
It is believed that more than 100 million vehicles could be affected around the world – many of which remain on the road.
| NEWS
by: Motley Rice
We're pleased to announce that Louis M. Bograd has joined the firm. In addition to expanding the firm’s work in appellate matters, Bograd will be involved in the firm’s active and growing role in complex multidistrict and mass tort litigation.
| NEWS
by: Motley Rice
Motley Rice LLC, sole lead counsel in In re Barrick Gold Securities Litigation, has reached a $140 million preliminary settlement with gold mining company Barrick Gold Corporation (NYSE: ABX), on behalf of shareholders.
| NEWS
by: Motley Rice
The South Gauteng High Court in Johannesburg has certified the first class action in South African history for sick workers, allowing gold miners suffering from silicosis and tuberculosis to proceed with their claims against 30 gold producers.
| NEWS
by: Motley Rice
NHTSA announced the urgent recall of 40 million faulty airbag inflators, adding to what was already the largest and most complex safety recall in U.S. History.
| NEWS
by: Motley Rice
The MDL Plaintiffs' Steering Committee leading the Volkswagen Emissions "Defeat Device" class actions is pleased to announce that they have reached an Agreement in Principle with Volkswagen regarding the claims of 2.0 liter TDI owners and lessees.
| NEWS
by: Motley Rice
Motley Rice aviation attorneys are reviewing the fatal crash of a sight-seeing helicopter on Monday, April 4, 2016 around 3:30 p.m.
| NEWS
by: Motley Rice
On Sunday, an Amtrak train carrying 341 passengers and traveling from New York, NY, to Savannah, Ga., collided with a backhoe on the track south of Philadelphia. Two Amtrak construction workers were killed and 37 people were injured during the crash.
| NEWS
by: Motley Rice
A St. Louis, Missouri, jury awarded the family of a woman who passed away from ovarian cancer $72 million. The woman used Johnson & Johnson’s baby powder for more than 35 years before she was diagnosed with ovarian cancer.
| NEWS
by: Motley Rice
The U.S. Food and Drug Administration released the next steps for Essure®, including two multipart actions in effort to provide women and physicians with better information about the potential risks associated with using Essure.